How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks?
Regeneron Pharmaceuticals has struggled to keep pace with the broader pharma market over the past year. Despite this underperformance, analysts see potential for growth, citing reasons for continued optimism.
3 days ago
2 mins read
